Login / Signup

Combination lipid-lowering therapy as first-line strategy in very high-risk patients.

Kausik K RayLaurens F ReeskampUlrich LaufsMaciej BanachFrançois MachSadberk Lale TokgözoğluDerek L ConnollyAnja J GerritsErik S G StroesLluis MasanaJohn J P Kastelein
Published in: European heart journal (2021)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • mesenchymal stem cells
  • bone marrow